Fierce Pharma

Theramex has opted out of the U.K.’s self-regulatory program for [...]

In a blow to Bayer, a U.S. federal judge in [...]

The FDA should strengthen the evidence required for drug approvals [...]

The legal back-and-forth over migraine meds from Teva and Eli [...]

Astellas will close a stem cell therapy site. GSK is [...]

Viatris and Teva Pharmaceutical Industries recently launched separate recalls related [...]

The FDA’s Pharmacy Compounding Advisory Committee will convene this summer [...]

Travere is eyeing a collective $3 billion U.S. opportunity for [...]

Even as Eli Lilly gets underway with its next major [...]

Protagonist Therapeutics-partnered Icotyde has the potential to become one of [...]